Austin, TX 12/13/2007 12:06:47 AM
Speak with other shareholders about: (OTCBB: GTRE), (OTCBB: EBOF), (OTCBB: SYBD).
Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the United States by Alexa.com/Amazon.com, has created one of the finest chat programs available for investors. Now you can chat real-time with like-minded individuals about your favorite stock. Visit Stockwire.com and click the Chat Live button at the top.
----------------------------------------------------------
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=GTRE
Gran Tierra Energy Inc. (OTCBB: GTRE) up 1.5% on 533,000 shares traded.
Gran Tierra Energy Inc. is an international oil and gas exploration and production company, headquartered in Calgary, Canada, incorporated and traded in the United States and operating in South America. On Dec. 11th 2007, the company announced that they have initiated drilling Costayaco-2 in the Chaza Block, located in the Putumayo Basin of southern Colombia. Costayaco-2 is the first of two delineation wells that will be drilled in the Costayaco field. Drilling is anticipated to take approximately one month with completion and testing operations to follow. The second delineation well, Costayaco-3, will be drilled in the first quarter of 2008 following completion of Costayaco-2.
----------------------------------------------------------
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=EBOF
Earth Biofuels, Inc. (OTCBB: EBOF) up 14% on 6.6 million shares traded.
Earth Biofuels produces and distributes biodiesel fuel through wholesale and retail outlets. The fuel is sold under Willie Nelson's brand name, "BioWillie(R)." Earth Biofuels also produces and markets liquefied natural gas (LNG) through its subsidiary, ALT LNG. The Company is focused on meeting the growing demand for alternative and renewable fuels in the domestic market. On Dec. 11th, the company announced that the petition for involuntary bankruptcy filed against the Company on July 11th of this year was dismissed yesterday, December 10th, 2007, by the U.S. Bankruptcy Court for the District of Delaware. The Company is no longer involved with any bankruptcy proceedings and is moving forward with its restructuring and growth plan. That plan is focused on the expansion of Company's liquefied natural gas business, the Company's biodiesel production and marketing operations, the development of cellulosic ethanol production technologies, and the development of biofuels retail marketing and distribution.
----------------------------------------------------------
To view in-depth research, click the following
link: http://www.stockwire.com/detailed/analysis.php?company=SYBD
Synthetic Blood International, Inc. (OTCBB: SYBD) up 14.2% on 3.2 million shares traded.
Synthetic Blood International is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. On Dec. 11th 2007, the company announced its plan to finalize a Phase IIb clinical trial protocol with Oxycyte(TM) for the treatment of traumatic brain injury (TBI) at its Scientific Advisory Board (SAB) meeting scheduled for Thursday, December 13, 2007. Oxycyte is Synthetic Blood's proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.
--------------------------------------------------
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at www.sec.gov and/or the National Association of Securities Dealers (NASDAQ) at www.NASDAQ.com. The NASDAQ has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
We often receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. On occasion, we also accept free-trading shares in a company that we cover. We intend to sell these shares into the open market.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
